Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
about
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.Reliability and validity of a revised version of the General Nutrition Knowledge QuestionnaireStudy protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service.Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS).Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years.Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up.The size of the treatment effect: do patients and proxies agree?Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosisTesting the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.Psychometric properties of four fear of falling rating scales in people with Parkinson's disease.Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort.Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson's disease.Living with chronic illness scale: international validation of a new self-report measure in Parkinson's disease.Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritisIndependent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA.Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worseningAssessing the stroke-specific quality of life for outcome measurement in stroke rehabilitation: minimal detectable change and clinically important difference.A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.Evaluating the psychometric properties of an e-based version of the 39-item Parkinson's Disease Questionnaire.Validation of the danish version of functional assessment of multiple sclerosis: a quality of life instrument.Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial.Development of a Performance-Based Measure of Executive Functions in Patients with Schizophrenia.Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life.Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyThe suitability of patient-based measures in the field of Parkinson's disease: a systematic review.Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population."Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis.Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.The Partners in Health scale for older adults: design and examination of its psychometric properties in a Dutch population of older adults.Development of competence scale for senior clinical nurses.Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.Home functioning profiles in people with multiple sclerosis and their relation to disease characteristics and psychosocial functioning.Service user involvement in the coproduction of a mental health nursing metric: The Therapeutic Engagement Questionnaire.Prevalence of Anxiety among Hungarian Subjects with Parkinson's Disease.Improving service delivery for relapse management in multiple sclerosis.Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.Psychometric Evaluation of the Parkinson's Disease Activities of Daily Living Scale.Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
P2860
Q30547644-31ACF596-0E46-4E14-94FE-C4014DFD9AACQ30564263-FF55E0FD-2955-4DA2-B9CC-D4D6447235FDQ30808930-4E14EC8C-71C1-41B7-A8EC-10190DF39BA4Q33259100-AEB1C4C8-5D68-4097-9B6E-3DCC9D2D1AD0Q33283471-B4E66548-937E-47F4-9CA4-F52C2F56CAD4Q33321691-F1524E49-F3F8-476E-A948-E750C8421AE3Q33338231-995D9644-6502-45B4-BA36-9787FBC936EEQ33421586-C2FB87CD-F63C-4B09-BF4D-46EE5F04BACBQ33606260-D83756F9-5260-4E35-A9B4-34177E8B5476Q33639572-9EDE947A-7788-4F90-91DD-1D3D726BA1F7Q33672868-4C00A932-2557-43EB-A249-AD7E498B1CA5Q33712460-4C92B4EA-3D1B-46A9-BE11-E1058D9F7659Q33749919-1360238A-4C5D-4465-9C0C-393E924EE548Q33917273-4F17A537-ACDA-48B4-8043-6D245F0EEDD7Q34008667-290EDCBB-BDE2-4099-91DB-80CBBBA6E0C7Q34481209-A1967014-D754-488F-9EE7-703C47C87CC5Q34513111-34C6C091-A04B-4EC0-A402-D53390A22D1EQ34556001-DF76637B-B2A3-4626-A0EF-41C564A1C81EQ34742770-9149267F-0CEE-4C69-8D25-D4BF962D87D9Q35030328-789B8F21-0A84-4FC6-9C6B-E727250AE97DQ35636325-DF9D4FF8-7C90-44C7-92E7-E8E1B5388151Q35736376-C01FC949-3417-47A5-9011-200F608A27A6Q35839695-D48667F3-6235-486C-8AA2-9571594A92BAQ36142420-CA9DB4AC-B73A-4CC9-9DC6-656D1BDACDA8Q36526965-F13A8D97-D147-422A-8A21-A2B4B7444462Q36828001-A409F0C7-6718-4AA2-9828-2F017C985B95Q38072197-7E56F469-5D4E-4153-9102-3B3A457C743DQ38772696-9B9D23ED-97DE-4FCC-B25A-78F1A40BDD1DQ39232497-55EA159C-C6FB-46F3-8C4C-F45906910DEAQ39313496-8F331190-3CD0-4567-9EDC-BFDEE5A02D69Q39407714-01D5D356-3ECB-4B19-9538-41EFDC7DA183Q39593085-52A56E2F-06AF-4E69-B48C-5254E46547F0Q40068279-0E0691A9-655D-4CD2-B41B-90F50CF73055Q40282975-113B666E-30AE-4AA8-9A0D-A36E9FCB7CCAQ41642678-036720EF-0B69-43EB-BBB5-78490FB0199AQ42706737-8E66157C-57F1-4A60-8C8D-E52751995443Q45036290-C565DF26-9D23-4C5D-8B90-5B0A2CDA29A1Q45775677-BB6385BD-BC42-431F-9179-D80EF621C1DFQ47106020-ABDC94A7-B306-43D0-84D0-983707FF8ECDQ47301574-71F75564-862E-4CEE-9013-3B57E139D5D1
P2860
Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Improving the evaluation of th ...... ient-based measure of outcome.
@ast
Improving the evaluation of th ...... ient-based measure of outcome.
@en
type
label
Improving the evaluation of th ...... ient-based measure of outcome.
@ast
Improving the evaluation of th ...... ient-based measure of outcome.
@en
prefLabel
Improving the evaluation of th ...... ient-based measure of outcome.
@ast
Improving the evaluation of th ...... ient-based measure of outcome.
@en
P2093
P356
P1476
Improving the evaluation of th ...... ient-based measure of outcome.
@en
P2093
A J Thompson
D L Lamping
J C Hobart
R Fitzpatrick
P304
P356
10.3310/HTA8090
P577
2004-03-01T00:00:00Z